Treatment with cyclophosphamide i.v. pulse therapy is an option for effective treatment of skin fibrosis in patients with early systemic sclerosis

Mostrar otras versiones (1)

OBJECTIVES: SSc is a autoimmune disease characterized by fibrosis of the skin and internal organs. There is a lack of evidence for the efficacy of i.v. CYC pulse therapy on skin thickening. We aimed to examine the response of i.v. CYC pulse therapy on skin thickening in our cohort of SSc patients an...

Descripción completa

Detalles Bibliográficos
Autores principales: Kersten, Brigit E, den Broeder, Nathan, van den Hoogen, Frank H J, Knaapen-Hans, Hanneke A K, van den Ende, Cornelia H M, Vonk, Madelon C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310100/
https://www.ncbi.nlm.nih.gov/pubmed/31628802
http://dx.doi.org/10.1093/rheumatology/kez487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310100/
https://www.ncbi.nlm.nih.gov/pubmed/31628802
http://dx.doi.org/10.1093/rheumatology/kez487

Ejemplares similares